Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study

Bevacizumab plus FOLFOX-4 regimen represents the first-line therapy in patients affected by metastatic colorectal cancer (mCRC). Hyperthermia has been considered an effective ancillary treatment for cancer therapy through several anti-tumor mechanisms, sharing with Bevacizumab the inhibition of angi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranieri, Girolamo, Laface, Carmelo, Laforgia, Mariarita, De Summa, Simona, Porcelli, Mariangela, Macina, Francesco, Ammendola, Michele, Molinari, Pasquale, Lauletta, Gianfranco, Di Palo, Alessandra, Rubini, Giuseppe, Ferrari, Cristina, Gadaleta, Cosmo Damiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670056/
https://www.ncbi.nlm.nih.gov/pubmed/33224885
http://dx.doi.org/10.3389/fonc.2020.590707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670056/
https://www.ncbi.nlm.nih.gov/pubmed/33224885
http://dx.doi.org/10.3389/fonc.2020.590707

Ejemplares similares